HKU Technology Transfer, Spin-offs, and the Entrepreneurship Ecosystem

The University of Hong Kong (HKU) Integrated Information Database · 04 Research Module This article traces how the University translates research into enterprise: the Technology Transfer Office (TTO) / Versitech, incubation (iDendron, TSSSU@HKU), and patents and spin-off/start-up companies. A named company is included only if its technological or personnel origins at HKU can be verified—to avoid mistaking a business that simply has a Hong Kong address for an HKU spin-off.

# 1. The Technology Transfer System: TTO and Versitech

HKU’s technology transfer is coordinated by the Technology Transfer Office (TTO), with the commercialisation arm being Versitech Limited—a wholly owned subsidiary of the University responsible for intellectual property management, licensing, and holding equity in spin-off companies. According to the Versitech Startups page^※, the TTO and Versitech drive the commercialisation of HKU research and participate as shareholders in numerous spin-offs.

A concrete case: as reported by a HKU press release^※, the University’s patented “Flow-through hybridization” technology has been widely applied by Hybribio (凱普生物), a biotechnology company listed on the Shenzhen Stock Exchange’s Growth Enterprise Market (GEM), with Versitech as one of its shareholders—a representative example of an HKU patent reaching the capital market through licensing.

# 2. Startup Incubation: iDendron and TSSSU@HKU

# 2.1 iDendron Innovation and Entrepreneurship Hub

According to a HKU press release^※, HKU’s Innovation and Entrepreneurship Hub, iDendron, was launched on 23 October 2017 on the first floor of Knowles Building (鈕魯詩樓), funded by the Azalea (1972) Endowment Fund with support from Sino Group, Stanley Chu, and others. Strategic partners included Hong Kong Science and Technology Parks Corporation, Cyberport, and the HK X-Tech Startup Platform. At launch, 20 teams of startups led by HKU students and young alumni moved in; flagship programmes include DreamCatchers, the Entrepreneurship Academy, and more. iDendron is operated with support from the TTO.

# 2.2 TSSSU@HKU and Incubation Programmes

According to HKU TTO news^※:

• The Technology Start-up Support Scheme for Universities (TSSSU) @HKU was launched in 2014; each startup can receive up to HK$1.5 million per year for a maximum of three years.
• In the 2019/2020 academic year covered by that report, 25 HKU startups received TSSSU@HKU funding; since 2014, the scheme has supported a total of 48 startups, of which 9 have entered Cyberport and 15 have entered Hong Kong Science Park programmes.
• The iDendron Incubation Programme (iIP) lasts six months and selected an initial cohort of 12 early-stage startups, matched with 21 mentors (HKU academics, entrepreneurs, venture capitalists, and industry experts).

# 3. Spin-off / Start-up Companies (Verified Cases)

According to Versitech’s “HKU Startup / Spin-off Companies” page^※, HKU spin-offs and startups span fields including biomedicine, robotics, marine technology, and health tech. A selection (all drawn from that official page):

# 3.1 Case Study: Novoheart’s “Heart-in-a-Jar”

Novoheart is one of the better-known HKU spin-offs. Multiple reports indicate that its founder, Professor Ronald Li (李登偉), formerly held a chair in stem cell and regenerative medicine at HKU and led a related research centre. Using stem cells and bioengineering, Novoheart created thumb-sized human “heart-in-a-jar” models that contract and “pump” blood, designed for preclinical drug testing. The model has been described in the media as the “world’s first” of its kind.

# 3.2 Case Study: archiREEF’s 3D-Printed Reef Tiles

archiREEF is a spin-off incubated at the intersection of architecture and marine science at HKU. According to an HKU press release^※, the Faculty of Architecture and marine scientists jointly developed 3D-printed “reef tiles” to provide surfaces for coral attachment and improve survival rates, with a pilot deployment at Hoi Ha Wan Marine Park in Sai Kung—an initial batch of 128 tiles, each roughly 600 mm in diameter, robotically 3D-printed in clay and fired at approximately 1,125°C. Multiple reports note that the team incorporated archiREEF in 2020 to commercialise the innovation; according to an SCMP report^※, the company aims to deploy the reef tiles globally to restore degraded marine ecosystems. This is a representative case of the “research–incubation–commercialisation” chain at HKU applied to environmental technology.

# 3.3 Student Entrepreneurship Seed Fund: DreamCatchers

According to iDendron / DreamCatchers material^※, HKU launched the student entrepreneurship seed fund DreamCatchers 100K in 2016 to support students and recent graduates starting out; winning teams can receive up to HK$100,000 in cash plus a membership to the iDendron co-working space. For instance, the 2018 DreamCatchers 100K final was held on 15 April, awarding four prizes of HK$100,000 each, four of HK$50,000 each, and free iDendron memberships. DreamCatchers, the MedTech Hackathon, and the Entrepreneurship Academy are among iDendron’s flagship incubation programmes.

# 4. Patents and Intellectual Property

HKU patents reach industry through Versitech licensing (exemplified by the “flow-through hybridization” technology mentioned above). A consolidated annual total of HKU’s patent applications, grants, and licensing income is reported across annual reports and TTO/Versitech disclosures; this Archive has not identified a single authoritative yearly total and marks this as data not available (for an overview of finances, see ../08-finances/).

# 5. Summary and Gaps

• Securely sourced: The TTO/Versitech mechanism, iDendron (2017, Knowles Building, Azalea fund), TSSSU@HKU (from 2014, up to HK$1.5m/year for three years, 48 startups cumulatively), the spin-off company list (official Versitech page), and the “flow-through hybridization” patent case are all supported by official HKU sources.
• Boundaries actively set: Insilico Medicine is not counted as an HKU spin-off (merely based in Hong Kong, not an institutional spin-off); the description of Novoheart’s “world’s first heart-in-a-jar” is attributed to media reports.
• Unavailable / deferred: A single authoritative figure for annual patent applications, grants, and licensing income (no data; see the finance module at ../08-finances/); for the full list of spin-offs and details on valuation/listing, refer to the official Versitech page^※—this Archive does not itemise valuations individually.